Cognitive Impairments in First-Episode Drug-Na ïve Versus Medicated Depressive Patients: RBANS in a Chinese Population

AbstractCognitive deficits are a core feature of major depressive disorder (MDD). However, there are no previous studies that directly compare cognitive performance between first-episode drug-naive depressive patients (FDDP) and medicated depressive patients (MDP). Therefore, the aim of this study was to investigate whether there were the differences in cognitive functions between FDDP and MDP. Sixty-two FDDP, 111 MDP and 90 healthy controls were enrolled in a Chinese population. Cognitive functions were assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). There were the differences in the RBANS total score (F  = 26.55,p <  0.001), subscales of immediate memory (F = 3.95,p = 0.02), language (F = 54.11, p <  0.001) and delayed memory (F = 11.19,p = 0.001) among the three groups after controlling for gender, education, smoking and body mass index (BMI). These differences in the RBANS total score, subscales of language and delayed memory passed the Bonferroni corrections (all,p <  0.05). Compared to healthy controls, FDDP and MDP had poorer cognitive performance including the RBANS total score, and subscales of language and delayed memory (all, p <  0.05) after controlling for the variables. FDDP experienced greater language deficits than MDP (p <  0.05) after controlling for the variables. Education was correlated with the language score in FDDP (r = 0.61,p <  0.001). Mult...
Source: Psychiatric Quarterly - Category: Psychiatry Source Type: research